With interest, we read the paper of Teama et al. 1 which investigated the association between vitamin D concentrations and the severity of coronavirus disease 2019 . More specifically, a high frequency of hypovitaminosis D in severe COVID-19 patients was observed, suggesting a potential association between vitamin D deficiency and a poor disease outcome. Despite the correlation between vitamin D deficiency and severe COVID-19, the potential protective role of vitamin D against severe COVID-19, based on its influence on both adaptive and innate immunity, remains unclear. 2 We would like to discuss the potential influence of vitamin D binding protein (DBP) and its polymorphisms on the reported results.DBP is the major serum transporter and reservoir of all circulating vitamin D metabolites. In healthy subjects, ∼85% of the vitamin D metabolites are bound with high affinity to DBP, whereas albumin binds ∼15% with low affinity. This member of the albumin and alpha-fetoprotein gene family is characterized by a considerable polymorphism with three major alleles determined by the single nucleotide polymorphisms (SNPs) rs7041 and rs4588 [DBP1F (rs7041-T/rs4588-C), DBP1S (rs7041-G/rs4588-C), and DBP2